BIOTTS AMONG THE CEBIOFORUM WINNERS 2019

We are pleased to inform you that our portfolio company BIOTTS was among the winners of the CBF Award competition start-up category in which the most innovative companies from the BioTech🔝 sector participated. The competition’s task is to reveal biotechnology companies and people from Central Europe that excel in innovation, through implementation of ambitious research and development projects. The aim of the competition is to select real leaders in the biotechnology sector of our Region, and one of the most important criteria is to be assessed in potential commercialisation of developed projects.

BIOTTS is a biotechnology company owner of proprietary, patented transdermal system (TTS) technology for the penetration of medicinal substances. 💊 It serves as a transporter for active natural or synthetic substances into the deeper tissues of the skin. The carrier can be used in the treatment of many diseases entities, including: atopic skin, skin inflammation, acne, prostate cancer, bacterial and viral infections of the skin, burns, difficult to heal wounds.

Congratulations to the BIOTTS  team! 👏

BIOCELTIX WINNER IN THE INDUSTRY OF LIFE SCIENCE DURING START-UP CHALLENGE 2019

On Tuesday (14th May) during the European Start-Up Days – event accompanying the 11th European Economic Congress in Katowice – prizes were distributed in the Start-Up Challenge competition.

18 start-ups have been selected from the record number of 300 entries to present their innovations. We are proud of Bioceltix, which have won in the category of medicine, health, medical technologies, pharmacy, biotechnology. The jury awarded Bioceltix for ambitious clinical research plan, developed business model and the ability to scale solutions. The team’s competences were also appreciated. Bioceltix is ​​one of the global pioneers implementing animal-safe and business-scaled technology of the therapeutic use of animal, allogenic (one donor – many recipients) stem cells.

We warmly congratulate the team Bioceltix 👏 We keep our fingers crossed for effective commercialization!

At the same time, we invite you to listen to the interview given by the president of Bioceltix for radio TOK FM – dr Łukasz Bzdzion. 🎧

 

THE POLES BRINGING A REVOLUTION IN VETERINARY – MONEY.PL ABOUT AMBITIOUS BIOCELTIX PLANS

 

We encourage you to read the article from Money.pl portal, which presents development plans for our portfolio company – Bioceltix.  The team of scientists led by Łukasz Bzdzion is working on innovative biological drugs used in the treatment of common diseases in animals that use immunomodulatory properties of mesenchymal stem cells (MSC).

 Bioceltix is ​​one of the first companies in the world planning to go through the full registration path in EMA for a veterinary biological medicine that uses MSC as an active substance. The registration needs to happen in order to place the drug on the market. In connection with this, the Wrocław startup conducts an individual dialogue with the Agency as part of scientific advice and meets a number of its stringent requirements.

 “The market for veterinary biological drugs is still in its infancy – only two years ago, the first biotechnology medicine was registered in EMA.  We intend to change it “- declares the president of Bioceltix, Łukasz Bzdzion.

Leonarto has been supporting Bioceltix in development since 2017, when the Fund’s investment took place in this extremely innovative and ground-breaking project.

Read the article

Photo – Bioceltix SA

FOREIGN LABORATORIES AUTOMATISED BY BIOAVLEE – PULS BIZNESU ABOUT OUR PORTFOLIO COMPANY

 

 

 

 

 

 

 

We encourage you to read the Business Pulse article, which presents the achievements of Bioavlee in terms of the current development and sale of products, but also presents company further plans that wants to primarily conquer foreign markets with its solutions. “The Polish market is not yet well-off enough for companies to invest in innovative equipment. Money goes to more urgent needs, and the labor cost of native laboratory technicians is still much lower than in Western Europe, “comments Michał Wronecki, President of Bioavlee. We also recommend the commentary of Magdalena Surowiec – the Managing Partner of our Fund who, is working on a daily basis with biotechnology companies under the Leonarto Fund wings, and is meeting the challenges and problems of startups in this very demanding industry.

NESTMEDIC WITH SUCCESS ON THE FINISH MARKET!

Nestmedic S.A. will deliver the Pregnabit system to the University Hospital in Helsinki (HUS). The order for the Pregnabit teleCTG devices and the license are the result of a successful pilot project carried out at HUS. The first full implementation on the Finnish market opens a new chapter in the expansion of the Pregnabit system in foreign markets.

“This is a very important project in the implementation of the foreign market expansion strategy for the hashtag#Pregnabit system. Our solution has been appreciated by a specialist hospital in a very demanding market. This is also the outcome of our successful cooperation with a business partner in Finland, Steripolar Finland (Head Office). With this project we are starting a new chapter in the development of our company on foreign markets”, comments  Sławomir Bartoszcze, Director of International Expansion at Nestmedic S.A.

Well done Nestmedic! Keep doing!

BIOTTS DOESN’T LEAVE THE PODIUM

 

In the middle of April an Innovation Forum was held at Solski Theatre in Tarnów. This was a conference focused entirely on innovation, start ups and disbursal economy! The 5th edition of Startup Award 🚀 was part of the conference dedicated to young entrepreneurs looking for funds to implement their innovative ideas. The I’m of the competition is to promote the best practices in the field of innovation used by Polish entrepreneurs. The competition was very strong, and as many as 84 projects presented their solutions.

We are pleased to inform you that the BIOTTS company from the Leonarto portfolio has taken the podium place
The BIOTTS company patented the technology of penetration of medicinal substances deep into the skin tissue. It will serve as a base for cosmetics and medicines. 💊
Congratulations to the BIOTTS team and we wish them productivity in further development!

APS WINNER IN THE COMPETITION “INNOVATIONS FOR SAFETY AND DEFENSE”

 

 

 

 

 

 

 

 

 

 

 

The mobile system for the detection and neutralization of drones CTRL + SKY of our portfolio company Advenced Protection Systems SA won the competition “Innovations for Safety and Defense” for the best projects described in the Catalog: Innovations – Implementations – Security – Defense. The competition was held under honorary patronage of the head of the National Security Bureau and the director of the National Center for Research and Development. The selection was made by BBN, NCBiR experts and the mundurowi.pl portal This is another distinction for APS, which has already made the first implementations of the innovative system. Congratulations to the APS team!

BIOAVLEE AND BIOCELTIX IN THE TOP 5 POLISH START-UP LIFESCIENCE

 

 

 

 

 

 

 

Biotechnologia.pl – a specialized industry portal – published a list of 5 Polish start-ups from the LifeScience industry, whose solutions can change the world. Among them were two start-ups present in Leonarto’s portfolio – Bioavlee and Bioceltix. 👏 As the editorial board writes – “(…) in Poland there were swarms of biotechnological and telemedicine start-ups, attracting investors and a wide stream of subsidies. The game is worth the candle – in the case of success, these projects will be worth billions. ”

We believe that this is how it will be. We invest in innovative industries as well as ambitious and ground-breaking projects whose implementations are carried out on a massive scale. Ambition and innovation are part of our DNA!

LEONARTO ALFA WITH INVESTMENT IN ED-TECH. THE NEW PORTFOLIO COMPANY – UNIVERSALITY











CAREER STARTS NOW AT STUDIES 🎓

Universality supports recruitment processes and competence development of students – future candidates for work during their studies. Universality.io platform is the largest database of practical programming tasks prepared by companies, available to lecturers enabling students at universities to acquire practical knowledge quickly and effectively. As part of the investment the team of Universality, lead by the project’s initiator – Jurek Czepiel, will develop a completely new functionality – AI Driven HR, which will be implemented in the form of a smart student and recruiter assistant. Universality’s strategy for the coming years assumes dynamic growth both among the universities as well as corporate clients.

Welcome Universality team on board and we will keep our fingers crossed for achieving goals Leonarto Alfa investment implemented in cooperation with #NCBR as part of the #BridgeAlfa program. National Center for Research and Development, thank you!

 

 

GENOMTEC – WINNER, BIOTTS – AWARDED, START-UP-MED COMPETITION RESOLVED

The Start-Up-Med competition is an event accompanying the Congress of Health Challenges. The aim of the competition is to select and distinguish start-ups – the most creative authors of innovative and at the same time to identify effective projects covering broadly understood medical technologies, both drug and non-drug (including medical devices, solutions in the field of diagnostics and teleinformation technologies), as well as organizational innovations that improve the functioning of various areas of the health care system.

As part of this year’s edition, the finalists included two companies from the Leonarto portfolio, GENOMTEC with the GENOMTEC ID and BIOTTS with their innovative transdermal system increasing the bioavailability of active substances. The jury of scientific experts, clinicians, Ministry of Health representatives, Agency for Health Technology Assessment and Tariffs, National Center for Research and Development, and leaders of the national medical industry, favoured GENOMTEC ID🏆—> the best solutions.

We congratulate both GENOMTEC and BIOTTS and wish you continued success in the development of innovative products and their commercialization.

APS WITH A NEW INVESTOR


The Ctrl + Sky antidronic system, created by Advanced Protection Systems, gains new buyers and recognition among investors. These systems are all ready being used at Norwegian airports, Czech security services and NATO troops. Zaleski Family- creators of the most innovative bank in Poland – Alior Bank – decided to invest in The Ctrl+Sky.
“I look at world technological innovations on a regular basis and it turns out that Poland is not lacking in them. So I decided to get involved in APS, offering a solution for global” challenges of the future “. APS is a leader in the industry, soon will be worth billions of dollars annually”emphasizes Helene Zaleski in a conversation with MamStartup.
Satisfaction is not concealed by the president of APS – dr Maciej Klemm: “The market of antidronic solutions is rapidly growing, so does the awareness of the need for protection. Systems for the detection and neutralization of drones is a necessity for maintaining security, which is evidenced by recent events at Gatwick and Heathrow airports.
Congratulations on APS!

XTPL DEBUTES ON THE WARSAW STOCK EXCHANGE (GPW)

Today, our portfolio company XTPL has been listed at the Warsaw Stock for the first time, making a first debut of 2019.

“Debut on the GPW is another stage in the development of our company, we are building a company with global ambitions. The cost-effective, simple and therefore scalable XTPL technology can completely change the way certain industries produces advanced electronics “- said Filip Granek, president and co-founder of XTPL after his debut.

The transition from the NewConnect market to the main trading floor of the GPW is aimed at attracting new institutional investors, both international and domestic, investing in groundbreaking innovations on a global scale. The next step will be to start the dual – listing at the Frankfurt Open Market.

At the same time, XTPL develops structures and intensifies operations in the USA, where it has just launched its branch in Silicon Valley. XTPL Inc. is to support key IP security processes and implementations in cooperation with industrial tycoons on the US market.

XTPL – congratulations and we wish you continued success!

GENOMTEC AWARDED IN THE COMPETITION POLISH PRODUCT OF THE FUTURE

GENOMTEC doesn’t slow down … We’ve just announced about acquiring nearly 9 million for further development and commercialization of technology in the Fast Track program. This time, we’re pleased to inform you about the prize and distinction that GENOMTEC received for the Genomtec ID solution, as part of the prestigious competition organized by PARP and NCBIR – Polish Product of the Future. In the Polish Product of the Future (Polski Produkt Przyszłości) competition, the most innovative Polish products and technologies are awarded. Genomtec received a distinction in the category: the future product of a joint projects (university and entrepreneur) and a special prize for a product created by a young entrepreneur. The awards were received by Genomtec CEO – Miron Tokarski. “Genomtec ID is a molecular biology laboratory in your pocket. It helps detect viruses in record time – less than 20 minutes. The technology can be used in diagnostics of people and animals. Its implementation will reduce the phenomenon of antibiotic resistance, reduce the incidence of side effects of drugs, speed up the treatment process and reduce the cost of treatment. ” Congratulations and we keep our fingers crossed for the fast commercialization! It’s a product that can help every one of us! 👏

GENOMTEC ON THE FAST TRACK

GENOMTEC received a positive evaluation of the National Center for Research and Development (NCBR) as part of the “Fast Track” competition. The company will receive nearly PLN 9 million in subsidies for further development of technology and product. Company develop Genomtec ID – handy, innovative diagnostic device based on the amplification and detection of specific DNA and RNA fragments – the “gold standard” of molecular diagnostics. This technology has a number of implementation possibilities in many areas of medicine, including the so-called liquid biopsy, immunological or biochemical tests.

The grant comes from the European Funds under the Intelligent Development Operational Program, thanks to which the National Center for Research and Development supports innovative solutions for micro, small and medium enterprises.

“With competitions such as the Fast Track, innovative solutions of start-ups like us are able to get a second wind” says Miron Tokarski, CEO of Genomtec.

Congratulations to the Genomtec team. We keep our fingers crossed for success!

XTPL GROWS STRONGER

XTPL technology is unique. It works and can be widely used. The company has a great opportunity to become the main provider of advanced solutions for several serious American or Asian companies. This will mean that XTPL has big business within its reach, really big”, said Dr Hendrik Leber, managing director of Acatis Investment, which controls more than 7% of XTPL shares.” The German Investor has long believed in the potential of XTPL and supported the development of innovative technologies with its investments.

Filip Granek, co-founder and CEO of XTPL, adds:

We’re entering the hottest period of our growth. We have chosen the key application areas for nanoprinting, which at this stage we believe to be optimal in terms of the relation between inputs and effects. They include, for example, open defects repair, semiconductors and smart glass markets – sectors that are extremely absorbent when it comes to innovation. In these areas, our additive technology for precise deposition of conductive structures can make an absolute breakthrough”🚀

XTPL will soon make its debut on the regulated market of the Warsaw Stock Exchange. The prospectus of the nanotechnology company has just been approved by the Polish Financial Supervision Authority. The change of the quotation system will open access to a wider base of institutional investors and will enable the start of efforts for a dual listing of the company on one of the Western European exchanges – informs a nanotechnology company on its website. Speaking in a football language, XTPL will advance to the top league and have the chance to play in international competitions. ”

XTPL’s interest is growing both at home and abroad. One example is the publication of Business Insider, which we highly recommend reading !!! ⬇

https://markets.businessinsider.com/news/stocks/xtpl-with-additional-capital-from-german-investors-sets-up-operating-structures-in-silicon-valley-1027884893

PKO BP IMPLEMENTS EMPLOBOT

Emplocity Founders – Arkadiusz Talun and Krzysztof Sobczak

2018 was a year of success for Emplocity. The company created a completely new product, started further R&D project on autonomous artificial intelligence, developed its structures and won numerous awards and challenges. All this means that today we do not talk about Emplocity as a startup, but about a full-fledged provider of Enterprise solutions, with which the largest brands such as mBank, Aviva and Santander cooperate. 2019 promises to be even better. Emplocity begins it with another success. The group of clients has expanded by PKO BP, the largest bank in Poland, which implements Emplobot – a recruitment bot created in Messenger. This is the next step of the bank in making digital transformation, part of which becomes now Emplocity. Congratulations to the entire Emplocity team and wish you continued success! We are happy that we can be part of this success.

To find out more click here.

QQN’S STOCK EXCHANGE DEBUT

We are pleased to inform you that on January 18, 2019, QuarticOn S.A. was first quoted on the NewConnect market.

QuarticOn is a technology company that creates IT applications operating in the SaaS model based on a computing cloud. The flagship products of the company are the engine of personalized recommendations for e-commerce along with the system for personalization of advertising creations addressed to the segment of medium-sized online stores (Segment Supreme) and a recommendation engine for video offered to large enterprises (Enterprise Segment). Since 2018, for both segments, QQN offer also a system for personalizing recommendations in e-mails.

QuarticOn S.A. is the 388th company listed on the NewConnect Market and the 2nd debut on this market in 2019.
Congratulations and we wish you further development and high quotations 🚀

Details related to the debut and more information about the Company can be found on the NewConnect official website. https://newconnect.pl/relacje-z-debiutow?ph_main_01_start=show&ph_main_01_cmn_id=16201&title=Pierwsze+notowanie+sp%C3%B3%C5%82ki+QUARTICON+S.A.+na+rynku+NewConnect

APS Ctrl+SKY SYSTEM INTEREST RAISED AFTER GATWICK DRONE DISASTER

48h standstill at Gatwick airport caused by sighting of a drone, began hot discussion in regards of airports safety from unmanned aircrafts. The question asked is to does the security system exists, which can prevent these incidents? The answer is Yes, and they are offered by our portfolio company – Advanced Protection System, which starts to implement the security of the system at Stavanger airport in Norway. The Norwegians saw the advantages of the Ctrl+Sky system and signed the contract at the end of last year. We hope that many other will follow Norwegian suite and APS will grow their wings to secure safe and on time flight. SkyNews during their poll on security from the drones didn’t give the ultimate answer if they do or don’t have the system, only that there is a plan to implement one and that the British Government ignored the problem for far too long. Will it be able to avoid Gatwick  drone disaster in the future? Or will it have to happen again?

Source: https://www.pb.pl/polacy-mogli-zlapac-drony-z-gatwick-950141

LEONARTO’S PORTFOLIO COMPANIES AGAIN AT THE TOP OF THE MIT ENTERPRISE FORUM PROGRAM

We are slowly getting used to the successes of our portfolio companies in leading acceleration programs. The success gained by Pregnabit in the 3rd and Genomtec in 4th edition of the MIT Enterprise Forum acceleration program wasn’t enough. The time has come for edition No5 and again our companies were at the top – Bioavlee and BIOTTS.
The winnings will give Bioavlee an amazing opportunity of trip to Boston to take part in a Bootcamp.
BIOTTS company for its distinction received Wroclaw Technology Park S.A vouchers.

To find out more use the link below

https://mamstartup.pl/akceleracja/14334/polskie-startupy-leca-do-bostonu-znamy-finalistow-5-edycji-programu-mit-enterprise-forum-poland?fbclid=IwAR2wQ-0ucrTq1iRp1o-2QO4cmdJ37yuI_ZGw_Ckwe23E21tTE5znTYHjges

XTPL ranked the best investment of 2018

End of the year is always the best time  to review the passing year. The website rentier.io created the ranking of investments which have been keenly invested by Polish people. The investments have been presented by the highest return of ROI in the last 12 months. We are happy to announce that the XTPL has been ranked the best (spolka portfelowa). This is a fantastic news, which make us proud and give us optimism for 2019!

Congratulations to XTPL and keep up the good work!

More about:

https://forsal.pl/artykuly/1388470,od-xtpl-po-idea-bank-ranking-najlepszych-i-najgorszych-inwestycji-2018-roku.html?fbclid=IwAR1K1mBUbf_NpvfaazsT5IxQuQvadkY–G9MP-mPWjvJztWeQYWnWZTZw3A

ROOMSAGE IN THE FINALS OF AI MASTERS PUBLICIS AWARDS

We are pleased to announce that Roomsage is among the five finalists of the prestigious AI Masters Publicis Awards. The competition is one of the initiatives related to the organization of the AI Masters conference, which will take place on January 24-25, 2019 in Berlin.

RoomSage is one of the world’s first advertising technology platforms for hotels and digital marketers, powered by ORA the most advanced Artificial Intelligence (AI) and Machine Learning (ML) algorithms co-developed with the leading American Ivy League university researchers.

On December 15, two companies that will take part in the grand finale will be announced.
On January 24, the AI Masters conference will host the award ceremony and the winner of the competition will receive, among others, a cash prize of 25,000 euros.

We keep our fingers crossed for winning!

BIOAVLEE SELLS FIRST QUANTICA 500 COLONY COUNTERS

At the end of November, Bioavlee, our portfolio company, received an order for eight pieces of Quantica 500 colony counters. The order was completed on the same day. This is the first sale of Quantica 500 devices implemented by Bioavlee.

Quantica 500 is a device created for a wide audience, enabling automatic counting of microorganism colonies in quantitative analyzes during microbiological tests. Quantica 500 is more efficient, faster and cheaper compared to competitive solutions. Thanks to an efficient algorithm, the Quantica 500 correctly sums up even merged colonies. This feature gives the Bioavlee device a significant advantage over existing standard solutions, having difficulties in separating this type of colonies.

The Company is in talks with foreign distributors regarding the sale of Quantica 500, among others in France, Great Britain, Germany, Croatia, Spain and Turkey. At the beginning of next year, Bioavlee will provide foreign distributors with a series of test equipment.

Congratulations on the first sale!

BIOCELTIX AMONG THE 5 FINALISTS OF THE CHIVAS VENTURE COMPETITION

Our portfolio company – Bioceltix – is among 5 startups that will compete for the victory in the grand finale of the national edition of the prestigious Chivas Venture competition.
The aim of the competition is to select and distinguish innovative startups that use their activities to solve social or environmental problems.

In the final round, which will take place on January 17 next year, the Jury will select one company that will represent Poland in the global final, competing with startups from 25 countries. The prize pool to be won in the competition is one million dollars.

Bioceltix changes the world! The company is the first in Europe to implement a safe animal-friendly and scalable business technology for the therapeutic use of allogeneic stem cells in a single donor – many recipients system.

Congratulations to the team and we keep our fingers crossed for victory!

APS WILL PROTECT AIRPORTS IN NORWAY AGAINST AERIAL THREATS

Our portfolio company Advanced Protection Systems (APS) announced a few days ago that its CTRL+SKY system will be used in Norway to protect airports from aerial threats.
The company signed a contract with AVINOR for the protection of the Stavanger airport, among others in the field of bird monitoring as well as detection and neutralization of drones.

Airports and surrounding areas are particularly vulnerable to intrusions of drones. Thanks to the multi-sensor design, the Ctrl+Sky system enables efficient detection and neutralization of drones both day and night, in 24/7 mode, in all weather conditions. The system guarantees the so-called “umbrella protection” without dead zones, which means that every flying intruder will be captured, and thus its neutralization will be possible.

Congratulations to the entire APS team for the next international cooperation and implementation!

NESTMEDIC WITH FOREIGN CONTRACTS. PREGNABIT GOES TO CONQUER FINLAND AND NIGERIA

Recent weeks have brought good news from Nestmedic – our portfolio company. The company continues the commercialization of the Pregnabit telemedical CTG solution for fetal health monitoring.
A few days ago, a distribution agreement was signed with the Nigerian company Health Cross Global Medical Solutions Limited. The contract concerns the distribution of the Pregnabit system in Nigeria, one of the world leaders in terms of fertility rate. As a result of the contract, only next year, about 295 devices for CTG testing at home will be brought to the Nigerian market.
This is the second agreement signed by Nestmedic with a foreign partner in the last few weeks. In the beginning of November, the Company announced that it had signed a cooperation agreement with a Finnish distributor, Steripolar Oy. The contract defines the commercial conditions of the distribution of the Pregnabit system in Finland.
(…) We are very pleased that we cooperate with a partner who has over 30 years of experience in the distribution of medical equipment, which gives us the opportunity to effectively commercialize our system on the Finnish market” – says Patrycja Wizińska-Socha, President of Nestmedic.
We congratulate the Nestmedic team on their success in foreign expansion and we keep our fingers crossed for further dynamic development of the Company.

Contact us